MDRX ALERT: The Law Offices of Vincent Wong Investigate Veradigm Inc. for Potential Violations of Securities Laws
NEW YORK, July 31, 2023 /PRNewswire/ -- Attention Veradigm Inc. ("Veradigm") (NASDAQ: MDRX) shareholders:
The Law Offices of Vincent Wong announce that an investigation has commenced into Veradigm and certain of its officers and directors regarding potential securities fraud. The investigation concerns, in part, the below:
Veradigm announced on February 28, 2023 that they had discovered internal control failures related to revenue recognition over the previous six quarters, resulting in misstated reported revenues during that time. This has led to an expected reduction in revenue of approximately $20 million dollars from what was reported in the third quarter of 2021 and what was expected to be reported in the fourth quarter of 2022. Veradigm is still evaluating the materiality of the misstatement to determine if prior periods will also require adjustment. Consequently, the company revised its 2023 guidance downward and announced a delay in filing its 2022 annual report. As a result, Veradigm's share price fell by up to 14.7% during intraday trading on March 1, 2023, causing harm to investors.
If you suffered a loss on your investment in Veradigm, contact us about potential recovery by using the link below. There is no cost or obligation to you.
https://www.wongesq.com/pslra-1/veradigm-class-action-submission-form?prid=42732&wire=4
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
E-Mail: vw@wongesq.com
View original content:https://www.prnewswire.com/news-releases/mdrx-alert-the-law-offices-of-vincent-wong-investigate-veradigm-inc-for-potential-violations-of-securities-laws-301888631.html
SOURCE The Law Offices of Vincent Wong
Ausgewählte Hebelprodukte auf Allscripts Healthcare Solutions
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Allscripts Healthcare Solutions
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Allscripts Healthcare Solutions Aktie News
Allscripts Healthcare Solutions Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Allscripts Healthcare Solutions nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.11.18 | Allscripts Healthcare Solutions Neutral | Cantor Fitzgerald | |
| 19.09.17 | Allscripts Healthcare Solutions Outperform | RBC Capital Markets | |
| 15.08.17 | Allscripts Healthcare Solutions Overweight | Cantor Fitzgerald | |
| 10.01.17 | Allscripts Healthcare Solutions Buy | Maxim Group | |
| 02.12.16 | Allscripts Healthcare Solutions Neutral | Dougherty & Company LLC |